Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 4Terminated 2

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Dermatologic 4

Conditions

Breast Neoplasms 14Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Lymphoma, Non-Hodgkin 5Lymphoma, Mantle-Cell 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Unspecified Adult Solid Tumor, Protocol Specific 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Melanoma 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Head and Neck Neoplasms 4Colonic Neoplasms 4Breast Neoplasms, Male 4Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Neoplasms, Plasma Cell 3Neoplasms 3Myeloproliferative Disorders 3Lymphoma 3Leukemia 3Hodgkin Disease 3Congenital Abnormalities 3Colorectal Neoplasms 3Carcinoma, Ovarian Epithelial 3Burkitt Lymphoma 3Sezary Syndrome 2

Interventions

Ipilimumab 114pembrolizumab 95Nivolumab 91aldesleukin 86Interleukin-2 57Cyclophosphamide 54Dacarbazine 52Vemurafenib 39trametinib 37Temozolomide 37incomplete Freund's adjuvant 35fludarabine phosphate 35sargramostim 32dabrafenib 32fludarabine 26Bevacizumab 26Paclitaxel 22MART-1 Antigen 21Granulocyte-Macrophage Colony-Stimulating Factor 21montanide ISA 51 20Interferon-alpha 20Cisplatin 20Carboplatin 19Sorafenib 18Introns 17Biopsy 17cobimetinib 16Radiosurgery 16atezolizumab 15Radiotherapy 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Melanoma × Immunoenzyme Techniques × Clear all
NCT00568763 2018-10-31

Radiofrequency Therapy-Induced Endogenous Heat-Shock Proteins With or Without Radiofrequency Ablation or Cryotherapy in Treating Patients With Stage IV Melanoma

Mayo Clinic

Phase 1 Completed
11 enrolled
Dermatologic

Melanoma

NCT00897520 2017-05-19

Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy

Eastern Cooperative Oncology Group

Completed
40 enrolled
Dermatologic

Melanoma

NCT00871481 2017-04-19

Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma

Fred Hutchinson Cancer Center

Phase 1/2 Completed
10 enrolled
Dermatologic

Melanoma

NCT00602199 2011-05-16

ABT-510 in Treating Patients With Metastatic Melanoma

Mayo Clinic

Phase 2 Completed
42 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡